drugset / Trial / NCT05188989
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of TPN171H in men with erectile dysfunction.
Timeline
- Start
- 2021-12-31
- Primary completion
- 2023-02-14
- Completion
- 2023-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TPN171H | Unknown | 2.5 mg | Oral |
| Subject | TPN171H | Unknown | 5 mg | Oral |
| Subject | TPN171H | Unknown | 10 mg | Oral |